These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15728237)

  • 1. Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy.
    Casciola-Rosen L; Nagaraju K; Plotz P; Wang K; Levine S; Gabrielson E; Corse A; Rosen A
    J Exp Med; 2005 Feb; 201(4):591-601. PubMed ID: 15728237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myositis Autoantigen Expression Correlates With Muscle Regeneration but Not Autoantibody Specificity.
    Pinal-Fernandez I; Amici DR; Parks CA; Derfoul A; Casal-Dominguez M; Pak K; Yeker R; Plotz P; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Paik JJ; Albayda J; Corse AM; Lloyd TE; Christopher-Stine L; Mammen AL
    Arthritis Rheumatol; 2019 Aug; 71(8):1371-1376. PubMed ID: 30861336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Jo-1 autoantibodies and the immunopathogenesis of autoimmune myositis.
    Tsui FW; Siminovitch KA
    Int Rev Immunol; 1991; 7(3):225-35. PubMed ID: 1721933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of disease: autoantigens as clues to the pathogenesis of myositis.
    Suber TL; Casciola-Rosen L; Rosen A
    Nat Clin Pract Rheumatol; 2008 Apr; 4(4):201-9. PubMed ID: 18319710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Required role of apoptotic myogenic precursors and toll-like receptor stimulation for the establishment of autoimmune myositis in experimental murine models.
    Sciorati C; Monno A; Ascherman DP; Seletti E; Manfredi AA; Rovere-Querini P
    Arthritis Rheumatol; 2015 Mar; 67(3):809-22. PubMed ID: 25504878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignancy-associated myositis].
    Shimizu J
    Brain Nerve; 2010 Apr; 62(4):427-32. PubMed ID: 20420184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lung as a possible target for the immune reaction in myositis.
    Danoff SK; Casciola-Rosen L
    Arthritis Res Ther; 2011 Jul; 13(4):230. PubMed ID: 21787440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of myositis specific autoantigens during post-natal myogenesis.
    Zampieri S; Biral D; Adami N; Ghirardello A; Rampudda ME; Tonello M; Doria A
    Neurol Res; 2008 Mar; 30(2):145-8. PubMed ID: 18397605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibody profile in myositis].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen.
    Casciola-Rosen LA; Pluta AF; Plotz PH; Cox AE; Morris S; Wigley FM; Petri M; Gelber AC; Rosen A
    Arthritis Rheum; 2001 Feb; 44(2):389-96. PubMed ID: 11229471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of major histocompatibility complex class I molecules in autoimmune myositis.
    Nagaraju K
    Curr Opin Rheumatol; 2005 Nov; 17(6):725-30. PubMed ID: 16224250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
    Koenig M; Fritzler MJ; Targoff IN; Troyanov Y; Senécal JL
    Arthritis Res Ther; 2007; 9(4):R78. PubMed ID: 17688695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis.
    Tidball JG; Wehling-Henricks M
    Curr Opin Rheumatol; 2005 Nov; 17(6):707-13. PubMed ID: 16224247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myositis autoantibodies: recent perspectives.
    Riddell V; Bagby S; McHugh N
    Curr Opin Rheumatol; 2020 Nov; 32(6):548-552. PubMed ID: 32890028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic mechanisms of disease in myositis: autoantigens as clues.
    Betteridge ZE; Gunawardena H; McHugh NJ
    Curr Opin Rheumatol; 2009 Nov; 21(6):604-9. PubMed ID: 19713851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular mechanisms in inflammatory myopathies.
    Hohlfeld R; Goebels N; Engel AG
    Baillieres Clin Neurol; 1993 Nov; 2(3):617-35. PubMed ID: 8156145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis.
    Gunawardena H; Betteridge ZE; McHugh NJ
    Curr Opin Rheumatol; 2008 Nov; 20(6):675-80. PubMed ID: 18946327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative splicing factor ASF/SF2 is down regulated in inflamed muscle.
    Xiong Z; Shaibani A; Li YP; Yan Y; Zhang S; Yang Y; Yang F; Wang H; Yang XF
    J Clin Pathol; 2006 Aug; 59(8):855-61. PubMed ID: 16574722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.